Safety
-
Ethrane (enflurane) liquid for inhalation
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – January 2010
ADVERSE REACTIONS
Postmarketing Events
- Cardiac Disorders: Cardiac arrest
- Hepatobiliary Disorders: Hepatic necrosis, Hepatic failure
-
-







